Bigul

UNICHEM LABORATORIES LTD. - 506690 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayUNICHEM LABORATORIES LTD. 2CINL99999MH1962PLC012451 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pradeep Bhandari Designation: Company Secretary EmailId: pradeep.bhandari@unichemlabs.com Name of the Chief Financial Officer: Sandip Ghume Designation: Deputy Chief Financial Officer EmailId: sandip.ghume@unichemlabs.com Date: 14/04/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
14-04-2020
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Clarification

With reference to Movement in Price, Unichem Laboratories Ltd has submitted to BSE a copy of clarification is enclosed.
31-03-2020
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Clarification sought from Unichem Laboratories Ltd

The Exchange has sought clarification from Unichem Laboratories Ltd on March 30th, 2020, with reference to Movement in Price.The reply is awaited.
30-03-2020
Bigul

Company news: USFDA conducts inspection at Unichem Lab's manufacturing unit

The United States Food and Drug Administration conducted inspection at Unichem Laboratories' Active Pharmaceutical Ingredients manufacturing unit loca
25-02-2020
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement Under Regulation 30 Of LODR

Announcement under Regulation 30 of LODR
24-02-2020
Bigul

Unichem, Macleods recall drugs for blood pressure, diabetes from US market

Unichem is recalling 1.91 crore units of Clonidine Hydrochloride tablets and Macleods is recalling 4,694 bottles of Pioglitazone and Metformin Hydrochloride tablets used for treating high BP
16-02-2020
Bigul

Unichem Laboratories Ltd - 506690 - Unaudited Results For The Quarter And 9 Months Ended 31/12/2019

Unaudited Results for the quarter and 9 months ended 31/12/2019
03-02-2020
Next Page
Close

Let's Open Free Demat Account